| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 06/08/1995 | WO1995015338A1 Chaperonin 10 |
| 06/08/1995 | WO1995015316A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |
| 06/07/1995 | EP0656213A1 Treatment of conditions and disease |
| 06/01/1995 | WO1995014785A1 Composition for the in vivo production of therapeutic products |
| 05/18/1995 | WO1995013364A1 In situ modification and manipulation of stem cells of the central nervous system |
| 05/18/1995 | WO1995013090A1 Improved interferon polymer conjugates |
| 05/16/1995 | US5416117 Cyclopropenone derivatives |
| 05/16/1995 | CA1335577C Superoxide dismutase analogs having novel binding properties |
| 05/11/1995 | WO1995012598A1 Benzo-fused macrocycles promote release of growth hormone |
| 05/11/1995 | WO1995007697A3 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 05/11/1995 | CA2174235A1 Benzo-fused macrocycles promote release of growth hormone |
| 05/10/1995 | EP0652001A1 Methods for treating per-menopausal syndrome |
| 05/04/1995 | WO1995011690A1 Desferrioxamine oral delivery system |
| 05/04/1995 | WO1994028132A3 Opioid receptors: compositions and methods |
| 05/03/1995 | EP0650495A1 Improved antiandrogens |
| 05/03/1995 | EP0650359A1 TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING THE ACTIVE SUBSTANCE 17-$g(b)-OESTRADIOL (ANHYDROUS) |
| 05/02/1995 | US5411982 Cycloalkylene azoles, and their use as aromatase inhibitors |
| 04/27/1995 | WO1995011254A1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors |
| 04/27/1995 | WO1995011029A1 Combination of bisphosphonates and growth hormone secretagogues |
| 04/27/1995 | CA2173333A1 Combination of bisphosphonates and growth hormone secretagogues |
| 04/26/1995 | CN1101916A Compounds |
| 04/26/1995 | CN1101915A New 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical compositions.. |
| 04/26/1995 | CN1101914A Compounds |
| 04/20/1995 | WO1995010506A1 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
| 04/20/1995 | WO1995010296A1 A library of glyco-peptides useful for identification of cell adhesion inhibitors |
| 04/20/1995 | CA2173990A1 A library of glyco-peptides useful for identification of cell adhesion inhibitors |
| 04/19/1995 | EP0648779A2 New 11-benzaldehyde oxime, 17-beta methoxy, 17 alpha methoxymethyl derivates of estradiene, a process for their preparation and pharmaceutical compositions containing them |
| 04/19/1995 | EP0648498A1 Physiologically active peptide compositions |
| 04/19/1995 | EP0541822B1 Novel calcitonin, and production and use thereof |
| 04/19/1995 | EP0497915B1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE |
| 04/19/1995 | EP0468042B1 HOMOLOGATED VITAMIN D2 COMPOUNDS AND THE CORRESPONDING 1alpha-HYDROXYLATED DERIVATIVES |
| 04/19/1995 | CN1101649A Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical |
| 04/18/1995 | US5407939 Fluorinated 17 β-substituted 4-aza-5 α-androstan-3-one derivatives |
| 04/16/1995 | CA2118093A1 Methods for the treatment of peri-menopausal syndrome |
| 04/11/1995 | US5405834 Prodrug derivatives of thyrotropin-releasing hormone (TRH) |
| 04/04/1995 | US5403851 Substituted tryptamines, phenalkylamines and related compounds |
| 04/04/1995 | US5403731 Reacting the enzyme with a 1,1'-carbonyldimidazole-modified water-soluble polyoxyalkylene glycol |
| 03/30/1995 | WO1995008630A1 Surface loop structural analogues of fibroblast growth factors |
| 03/30/1995 | WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 03/29/1995 | EP0645450A1 Human calcitonin precursor polyprotein structural gene |
| 03/29/1995 | CN1100721A Imidazopyridine |
| 03/23/1995 | WO1995007926A1 Androstenones |
| 03/23/1995 | WO1995007699A1 Novel method of progesterone delivery and affect thereof |
| 03/23/1995 | WO1995007697A2 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 03/23/1995 | WO1995007694A1 Use of thiazolidinediones to prevent or delay onset of niddm |
| 03/23/1995 | CA2168751A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 03/22/1995 | EP0299050B1 Isolation of single chain proteins with fsh suppressing activity from follicular fluid |
| 03/09/1995 | WO1995006472A1 Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process |
| 03/09/1995 | CA2148373A1 Delta 5-androstenes useful for promoting weight maintenance or weight loss and treatment process |
| 03/08/1995 | EP0641791A1 Novel benzothiophene derivative |
| 03/08/1995 | EP0641355A1 Steroid sulphatase inhibitors |
| 03/08/1995 | EP0641329A1 Compounds having angiotensine ii antagonistic activity |
| 03/08/1995 | EP0641211A1 INHIBITORS OF TESTOSTERONE 5$g(a)-REDUCTASE ACTIVITY |
| 03/07/1995 | US5395842 Inhibitors of sex steroids |
| 03/07/1995 | CA1334668C 13-alkyl-11beta-phenylgonanes |
| 03/02/1995 | WO1995005833A1 Pharmaceutical composition for immunoenhancement therapy |
| 03/02/1995 | WO1995005827A1 Agent for transdermal application containing gestoden esters |
| 03/02/1995 | CA2170371A1 Agent for transdermal administration that contains gestodene esters |
| 03/01/1995 | EP0640072A1 Substituted pyridines, their preparation and pharmaceutical use |
| 02/28/1995 | US5393869 Polypeptides; hormone therapy for osteoporosis, hypertension and hypoparathyroidism |
| 02/23/1995 | WO1995005452A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 02/21/1995 | US5391557 Administering substituted 2-phenyl-3-aroylbenzothiophenes; reduced side effects |
| 02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
| 02/16/1995 | WO1995004541A1 N-terminus modified analogs of lhrh |
| 02/16/1995 | CA2167834A1 N-terminus modified analogs of lhrh |
| 02/14/1995 | US5389670 Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder |
| 02/14/1995 | US5389659 C-linked pyrazole derivatives |
| 02/09/1995 | WO1995004070A1 15,15-dialkyl-substituted derivatives of estradiol |
| 02/09/1995 | WO1995003817A1 Method of treating reproductive disorders |
| 02/09/1995 | WO1995003764A1 Skin patches and methods for providing testosterone |
| 02/09/1995 | CA2168790A1 Method of treating reproductive disorders |
| 02/09/1995 | CA2168657A1 15,15-dialkyl-substituted derivatives of estradiol |
| 02/08/1995 | EP0637297A1 Compounds having selectivity for retinoid x receptors |
| 02/07/1995 | US5387615 L-deprenyl for treating immune system dysfunction and compositions for same |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003290A1 Benzo-fused lactams promote release of growth hormone |
| 02/02/1995 | WO1995003285A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | CA2167507A1 Benzo-fused lactams promote release of growth hormone |
| 02/02/1995 | CA2167308A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 01/25/1995 | EP0635573A2 Process for the preparation of native human glicentin |
| 01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
| 01/25/1995 | EP0516849B1 Indole derivatives |
| 01/25/1995 | EP0480939B1 Heterocyclic amines having central nervous system activity |
| 01/17/1995 | US5382669 Process for the preparation of ergoline derivatives |
| 01/11/1995 | EP0632794A1 Method for separating enantiomers of aryloxipropanolamine derivatives, and chiral solid-phase chromatography material for use in the method |
| 01/10/1995 | CA1333892C Insulin-selective somatostatin analogs |
| 01/05/1995 | WO1995000147A1 4-AZA-PREGNANE 5α-REDUCTASE ISOZYME 1 INHIBITORS |
| 01/05/1995 | WO1995000135A1 Medical treatment using thyroid hormones |
| 01/05/1995 | CA2165822A1 The medical treatment using thyroid hormones |
| 01/05/1995 | CA2165077A1 4-aza-pregnane 5.alpha.-reductase isozyme 1 inhibitors |
| 12/31/1994 | CA2127068A1 Process for the preparation of native human glicentin |
| 12/27/1994 | US5376669 Antitumor agents |
| 12/27/1994 | US5376667 Derivatives of benzoylecgonine, ecgonine and their multiple pharmacological properties |
| 12/27/1994 | US5376637 Pharmaceutical preparation containing vasoactive intestinal polypeptide or its analogue |
| 12/21/1994 | EP0629635A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them |
| 12/20/1994 | CA1333616C 19-nor-vitamin d compounds |
| 12/20/1994 | CA1333597C 16,17-acetalsubstituted androstane-17.beta.-carboxylic acid esters |
| 12/18/1994 | CA2126158A1 19-nor steroids phenoxyalkylsulfonamide or phenoxyalkylsulfonylurea chain on 11 beta position, process and intermediates for their preparation, application as medicaments and pharmaceutical compositions containing them |